新型血栓与止血分子标志物在急性冠脉综合征中的研究进展
Research Progress of Novel Thrombus and Hemostatic Molecular Markers in Acute Coronary Syndrome
DOI: 10.12677/ACM.2020.1011375, PDF,   
作者: 王 哲, 齐 微, 王 悦, 夜雪敏：延安大学医学院，陕西 延安；邢延芳*：延安大学附属东关分院检验科，陕西 延安
关键词: 急性冠脉综合征；血栓与止血分子标志物；Acute Coronary Syndrome； Thrombus and Hemostasis Molecular Markers
摘要: 急性冠脉综合征是严重的心血管疾病，可并发恶性心律失常、急性心力衰竭和心脏破裂等，常可危及生命，是冠心病中的危重类型，早期诊断对疾病的治疗效果与后续恢复至关重要。本文就新型血栓与止血分子标志物在急性冠脉综合征的早期诊断做一综述。
Abstract: Acute coronary syndrome is a serious cardiovascular disease that can be complicated by malignant arrhythmia, acute heart failure, and heart rupture. It can often be life-threatening. It is a critical type of coronary heart disease. Early diagnosis is critical to the treatment effect and subsequent recovery of the disease. This article reviews the early diagnosis of acute coronary syndrome by new molecular markers of thrombosis and hemostasis.
文章引用：王哲, 齐微, 王悦, 夜雪敏, 邢延芳. 新型血栓与止血分子标志物在急性冠脉综合征中的研究进展[J]. 临床医学进展, 2020, 10(11): 2487-2492. https://doi.org/10.12677/ACM.2020.1011375

参考文献

[1] Hansson, G.K. (2005) Inflammation, Atherosclerosis, and Coronary Artery Disease. New England Journal of Medicine, 352, 1685-1695. [Google Scholar] [CrossRef] 
[2] 王琳. 血清H-FABP水平变化对急性心肌梗死早期诊断作用的初步分析[J]. 微循环学杂志, 2014, 24(2): 66-67.
[3] 董炤, 刘秀珍, 刘从彬, 等. 血栓调节蛋白的临床研究进展[J]. 安徽医药, 2010, 14(4): 383-384.
[4] Mosnier, L.O., Meijers, J.C. and Bouma, B.N. (2001) Regulation of Fibrinolysis in Plasma by TAFI and Protein C Is Dependent on the Concentration of Thrombomodulin. Thrombosis and Haemostasis, 85, 5-11. [Google Scholar] [CrossRef] 
[5] Wu, Y.Z., Chang, L.H., Ren, H., et al. (2010) Changes of Thrombomodulin and Thrombomodulin Ala455Val Polymorphism(C14181) in Chinese Han Patients with Acute Cerebrovascular Diseases. International Journal of Cerebrovascular Disease, 18, 21-25.
[6] Tran, N.D., Wang, L., et al. (1998) Measurement of Thrombomodulin m RNA Expression in Brain Capillaries by Polymerase Chain Reaction. Thrombosis Research, 91, 191-197. [Google Scholar] [CrossRef] 
[7] Krumholz, H.M. (1997) Platelet Receptor Inhibition for Ischemic Syndromes. Journal Watch Cardiology, 338, 1498-1505.
[8] 黄丽红, 郭民, 侯纯荣, 孟眷. 急性冠脉综合征患者血栓调节蛋白水平及临床意义[J]. 中国医药导报, 2009, 6(28): 25-26.
[9] Uno, M., Tsuji, H., Watanabe, M., et al. (1989) Application of Thrombin Antithrombin & Complex for Detecting a Latent Hypercoagulable State in Patients with Coronary Heart Disease. Japanese Circulation Journal, 53, 1185-1195. [Google Scholar] [CrossRef] [PubMed]
[10] 潘志红, 张江蓉, 袁惠敏, 等. 老年人血栓调节蛋白与冠状动脉病变的相关性研究[J]. 中国综合临床, 2007(12): 1059-1060.
[11] 吴方, 王学锋. 高凝状态患者止凝血分子标志物的检测及其临床意义[J]. 上海医学检验杂志, 2000, 15(3): 180-182.
[12] 沈培辰, 张代富, 王娟, 马兰. 急性心肌梗死患者血浆TAT变化的价值[J]. 实用全科医学, 2005, 3(6): 477-478.
[13] Giannitsis, E., Siemens, H.J., Mitusch, R., et al. (1999) Prothrombin Fragments F1+2, Thrombin Antithrombin & Complex, Fibrin Monomers and Fibrinogen in Patients with Coronary Atherosclerosis. International Journal of Cardiology, 68, 269-274. [Google Scholar] [CrossRef] 
[14] 吕永楠, 任玮, 陈晶晶, 李晓艳. 急性心肌梗死患者血栓标志物水平变化及意义[J]. 微循环学杂志, 2017, 27(3): 43-46.
[15] Kooistra, T., Schrauwen, Y., Arts, J., et al. (1994) Regulation of Endothelial Cell t-PA Synthesis and Release. International Journal of Hematology, 59, 233-255.
[16] Chandler, W.L., Trimble, S.L., Loo, S.C., et al. (1990) Effect of PAI-1 Levels on the Molar Concentrations of Active Tissue Plasminogen Activator (t-PA) and t-PA/PAI-1 Complex in Plasma. Blood, 76, 930-937. [Google Scholar] [CrossRef] 
[17] Pia, L., Niklas, B., Emma, L., Erik, U., Mia, M., Karin, W., Lena, K. and Sverker, J. (2013) Histone Deacetylase Inhibitors Stimulate Tissue-Type Plasminogen Activator Production in Vascular Endothelial Cells. Journal of Thrombosis and Thrombolysis, 35, 185-192. [Google Scholar] [CrossRef] [PubMed]
[18] Fox, K.A., Robison, A.K., Knabb, R.M., Rosamond, T.L., Sobel, B.E., et al. (1985) Prevention of Coronary Thrombosis with Subthrombolytic Doses of Tissue-Type Plasminogen Activator. Circulation, 72, 1346-1354. [Google Scholar] [CrossRef] 
[19] Giles, A.R., Nesheim, M.E., Herring, S.W., Hoogendoorn, H., Stump, D.C., et al. (1990) The Fibrinolytic Potential of the Normal Primate Following the Generation of Thrombin in Vivo. Thrombosis and Haemostasis, 63, 476-481. [Google Scholar] [CrossRef] 
[20] Oliver, J.J., Webb, D.J. and Newby, D.E. (2006) Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2470-2479. [Google Scholar] [CrossRef] 
[21] Hrafnkelsdottir, T., Gudnason, T., Wall, U., et al. (2004) Regulation of Local Availability of Active Tissue-Type Plasminogen Activator in Vivo in Man. Journal of Thrombosis and Haemostasis, 2, 1960-1968. [Google Scholar] [CrossRef] [PubMed]
[22] Salame, M.Y., Samani, N.J., Masood, I., et al. (2000) Expression of the Plasminogen Activator System in the Human Vascular Wall. Atherosclerosis, 152, 19-28. [Google Scholar] [CrossRef] 
[23] Shantsila, E., Montoro-García, S., Tapp, L.D., et al. (2012) Fibrinolytic Status in Acute Coronary Syndromes: Evidence of Differences in Relation to Clinical Features and Pathophysiological Pathways. Thrombosis and Haemostasis, 108, 32-40. [Google Scholar] [CrossRef] 
[24] Lijnen, H.R. and Collen, D. (1996) Impaired Fibrinolysis and the Risk for Coronary Heart Disease. Circulation, 94, 2052-2054. [Google Scholar] [CrossRef] 
[25] Robinson, S.D., Ludlam, C.A., Boon, N.A., et al. (2007) Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients with Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1651-1656. [Google Scholar] [CrossRef] 
[26] Galvani, M., Ferrini, D., Ottani, F., et al. (1999) Early Risk Stratification of Unstable Angina/non-Q Myocardial Infarction: Biochemical Markers of Coronary Thrombosis. International Journal of Cardiology, 68, S55-S61. [Google Scholar] [CrossRef] 
[27] 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220.
[28] 高润霖, 张澍, 王增武, 等. 新中国成立七十年来我国心血管病学的发展[J]. 中国循环杂志, 2019, 34(9): 833-843.
[29] Negreva, M., Georgiev, S., Prodanova, K., et al. (2016) Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in the Patients with Paroxysmal Atrial Fibrillation. Cardiology Research, 7, 89-94. [Google Scholar] [CrossRef] [PubMed]

为你推荐